monoclonal antibodies
-
Greg Fenton Discusses Zentek’s 2024 Progress and Exclusive Aptamer Technology Rights
In a detailed interview with Tracy Weslosky, Greg Fenton, CEO and Director of Zentek Ltd. (NASDAQ: ZTEK |…
-
Greg Fenton on how Zentek’s Advancement in Aptamer Technology is Revolutionizing Biotech
In an interview with host Tracy Weslosky from InvestorNews, Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO Greg…